"The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.
HER2 is a protein involved in normal cell growth. It is foun"...
Abraxane Patient Information including How Should I Take
In this Article
- What is paclitaxel protein-bound (Abraxane)?
- What are the possible side effects of paclitaxel protein-bound (Abraxane)?
- What is the most important information I should know about paclitaxel protein-bound (Abraxane)?
- What should I discuss with my healthcare provider before receiving paclitaxel protein-bound (Abraxane)?
- How is paclitaxel protein-bound given (Abraxane)?
- What happens if I miss a dose (Abraxane)?
- What happens if I overdose (Abraxane)?
- What should I avoid while using paclitaxel protein-bound (Abraxane)?
- What other drugs will affect paclitaxel protein-bound (Abraxane)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving paclitaxel protein-bound (Abraxane)?
You should not use paclitaxel protein-bound if you are allergic to it, or if you have a low white blood cell count.
To make sure you can safely receive paclitaxel protein-bound, tell your doctor if you have any of these other conditions:
- kidney disease;
- liver disease;
- heart disease, heart rhythm disorder; or
- bone marrow suppression.
FDA pregnancy category D. Do not use paclitaxel protein-bound if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
Use birth control to prevent pregnancy while you are receiving paclitaxel protein-bound, whether you are a man or a woman. Paclitaxel protein-bound use by either parent may cause birth defects.
It is not known whether paclitaxel protein-bound passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving paclitaxel protein-bound.
How is paclitaxel protein-bound given (Abraxane)?
Paclitaxel protein-bound is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. Paclitaxel protein-bound must be given slowly, and the IV infusion can take at least 30 minutes to complete.
Paclitaxel protein-bound is usually given once every 3 weeks. Follow your doctor's dosing instructions very carefully.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when paclitaxel protein-bound is injected.
To make sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Do not miss any follow-up visits to your doctor.
Additional Abraxane Information
Abraxane - User Reviews
Abraxane User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.